Junmei Lu
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology 16
-
- Mycobacterium research and diagnosis 14
-
- Cancer therapeutics and mechanisms 3
- Advanced biosensing and bioanalysis techniques 3
-
- Biosensors and Analytical Detection 2
-
- Bacteriophages and microbial interactions 5
-
- Infectious Diseases and Tuberculosis 4
-
- Monoclonal and Polyclonal Antibodies Research 2
- Journals
- Clinical Chemistry and Laboratory Medicine (CCLM) (2 papers)Applied Microbiology and Biotechnology (2 papers)BMC Infectious Diseases (2 papers)
- Partner nations
- ChinaJordanUnited States
In The Last Decade
Junmei Lu
21 papers receiving 389 citations
Peers
Comparison fields: 5 of 70
- Infectious Diseases 235
- Molecular Medicine 26
- Epidemiology 179
- Molecular Biology 148
- Biomedical Engineering 82
Countries citing papers authored by Junmei Lu
This map shows the geographic impact of Junmei Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junmei Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junmei Lu more than expected).
Fields of papers citing papers by Junmei Lu
This network shows the impact of papers produced by Junmei Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junmei Lu. The network helps show where Junmei Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Junmei Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 19 | |
| 2 | 2015 | 5 | |
| 3 | 2015 | 26 | |
| 4 | 2014 | 101 | |
| 5 | 2014 | 19 | |
| 6 | [Evaluation of the RNA simultaneous amplification and testing for detection of rifampin resistance in Mycobacterium tuberculosis]. | 2014 | 2 |
| 7 | 2014 | 37 | |
| 8 | 2013 | 3 | |
| 9 | [Methodology research and preliminary assessment of Mycobacterium tuberculosis detection by immunomagnetic beads combined with functionalized fluorescent quantum dots]. | 2013 | 2 |
| 10 | 2013 | 35 | |
| 11 | 2012 | 10 | |
| 12 | 2011 | 7 | |
| 13 | 2011 | 46 | |
| 14 | 2011 | 0 | |
| 15 | Optimization conditions on determination contents of Se in Yunnan Pu'er tea | 2010 | 1 |
| 16 | 2010 | 31 | |
| 17 | [The effects of gene mutation related to drug resistance and drug efflux pump in extensively drug-resistant tuberculosis clinical isolates]. | 2010 | 1 |
| 18 | 2010 | 12 | |
| 19 | 2009 | 43 | |
| 20 | [Evaluation of pyrosequencing for the detection of rpoB gene mutation in Mycobacterium tuberculosis]. | 2008 | 1 |
About Junmei Lu
Junmei Lu is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Ecology and Microbiology, having authored 22 papers that have together received 406 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (16 papers), Mycobacterium research and diagnosis (14 papers), Bacteriophages and microbial interactions (5 papers), Infectious Diseases and Tuberculosis (4 papers), Cancer therapeutics and mechanisms (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Biosensors and Analytical Detection (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Infectious Diseases (235 citations), Molecular Medicine (26 citations), Epidemiology (179 citations), Molecular Biology (148 citations) and Biomedical Engineering (82 citations). Junmei Lu has collaborated with scholars based in China, Jordan and United States. Frequent co-authors include Zhongyi Hu, Lianhua Qin, Hua Yang, Zhenling Cui, Ruijuan Zheng, Xiaochen Huang, Jie Wang, Hui Ma, Xiaochen Huang and Zhonghua Liu. Their work appears in journals such as Clinical Chemistry and Laboratory Medicine (CCLM), Applied Microbiology and Biotechnology, BMC Infectious Diseases, PLoS ONE and Food Science and Technology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.